| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mm-111 | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Adenocarcinoma[MeSHID:D000230] Stomach[MeSHID:D013270] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.07 | phase 2 | antibody |
| mm-111 | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Adenocarcinoma[MeSHID:D000230] Stomach[MeSHID:D013270] Malignant neoplasm of breast[MeSHID:D001943] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.07 | phase 2 | unknown |
| click here to return to the previous page | ||||||||